Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 19: 1152-1157, 1973;
This Article
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Romano, A. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Romano, A. T.

Clinical Chemistry, Vol 19, 1152-1157, Copyright © 1973 by the American Association for Clinical Chemistry

Automated Glucose Methods: Evaluation of a Glucose Oxidase—Peroxidase Procedure

Anna T. Romano 1

1 331 Willow Avenue, Hoboken, N. J. 07030.

We have evaluated methods in which glucose oxidase is used to determine serum glucose with the "AutoAnalyzer-II" and "SMA 12/60" (Technicon). A glucose oxidase—peroxidase—dianisidine procedure with improved specificity developed during this study is described. The glucose value is unaffected by the presence of 16 mg of uric acid per deciliter, and the system is highly resistant to interference from many other reducing compounds added to serum. The method appears to give "true glucose" values for normal, hyperuricemic, and uremic subjects. Results are compared with those from the "GOD-Perid," glucose oxidase—peroxidase—MBTH—DMA, hexokinase, toluidine, ferricyanide, and SMA 12/60 neocuproine techniques, as well as with those from our index of "true glucose," a procedure based on measurement of reducing material before and after treatment with glucose oxidase. Specificity and performance of the glucose oxidase—peroxidase—dianisidine and glucose oxidase—peroxidase—MBTH—DMA procedures are similar.


Key Words: comparison with "GOD-Perid." glucose oxidase—peroxidase—MBTH—DMA, hexokinase, toluidine, ferricyanide, and neocuproine methods • AutoAnalyzer • kit methods

Submitted on June 13, 1973
Accepted on August 8, 1973




The following articles in journals at HighWire Press have cited this article:


Home page
JAMAHome page
R. H. Knopp, C. E. Walden, B. M. Retzlaff, B. S. McCann, A. A. Dowdy, J. J. Albers, G. O. Gey, and M. N. Cooper
Long-term Cholesterol-Lowering Effects of 4 Fat-Restricted Diets in Hypercholesterolemic and Combined Hyperlipidemic Men: The Dietary Alternatives Study
JAMA, November 12, 1997; 278(18): 1509 - 1515.
[Abstract] [PDF]


Home page
JAMAHome page
M. S. Magee, C. E. Walden, T. J. Benedetti, and R. H. Knopp
Influence of Diagnostic Criteria on the Incidence of Gestational Diabetes and Perinatal Morbidity
JAMA, February 3, 1993; 269(5): 609 - 615.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1973 by the American Association for Clinical Chemistry.